CLOV vs RGEN · rev $1.37B vs P/E 143, $7.43B cap
Clover Health Investments Corp (CLOV) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
RGEN does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the CLOV and RGEN stock pages for the full models.
Not investment advice.